Media Releases

3 March, 2021

A new vaccine factsheet released by the Royal College of Pathologists of Australasia (RCPA) reassures the community that all vaccines are thoroughly tested for safety and efficacy before they are approved for use in Australia and New Zealand. This comes following the start of one of the largest and most complex immunisation programs in both Australia and New Zealand, an incredible milestone and achievement for the two nations.

15 February, 2021

The Royal College of Pathologists of Australasia (RCPA) raises serious concerns over changes made by the Therapeutic Goods Association (TGA) to a legal instrument which regulates certain self-testing in vitro diagnostic medical devices (IVDs) in Australia. The changes come following a consultation by the TGA to review what tests the association will allow manufacturers to provide directly to patients to perform on themselves.

27 November, 2020

The Royal College of Pathologists of Australasia (RCPA) is delighted that one of its Fellows, Professor Richard Scolyer has been awarded "Outstanding Researcher of the Year" in the NSW Premier's Awards for Outstanding Cancer Research 2020, presented by NSW Cancer Institute. This is one of the biggest awards of its kind that a researcher can receive and marks the first time that a pathologist has ever received this honour.

20 October, 2020

Following an application by the Royal College of Pathologists of Australasia (RCPA), the Medical Services Advisory Committee (MSAC) has recommended to the Health Minister, Greg Hunt, that reproductive carrier screening for fragile X syndrome (FXS), spinal muscular atrophy (SMA) and cystic fibrosis (CF) be listed on the Medicare Benefits Schedule (MBS).

1 October, 2020

The Royal College of Pathologists of Australasia (RCPA) advises against the widespread use of rapid antigen test for the diagnosis of COVID-19 in Australia and New Zealand in the current context of low prevalence of COVID-19 infections. As outlined in a new position statement from the RCPA, the preferred method for COVID-19 diagnosis is Polymerase Chain Reaction (PCR) molecular testing for the SARS-COV-2 virus, due to its high sensitivity and specificity.

8 July, 2020

The Royal College of Pathologists of Australasia (RCPA) is pleased to announce that, according
to the 2019 Journal Citation Reports (JCR), Pathology, the RCPA’s official journal, has increased
its impact factor to 3.744, which is an increase of 18.4% on the previous year. In addition,   the
overall   ranking   of Pathology has increased,   soaring five places    to be listed 16 out of 78
pathology titles.

6 July, 2020

The Royal College of Pathologists of Australasia (RCPA) strongly recommends that individuals continue to visit their GP to vaccinate children in accordance with the National Immunisation Program (NIP) Schedule in Australia and the National Immunisation Schedule in New Zealand. This year, for the first time, all children aged six months to five years of age are eligible to receive a free influenza vaccine under the NIP Schedule.

9 June, 2020

As social distancing measures begin to ease, the Royal College of Pathologists of Australasia (RCPA) explains that maintaining high levels Polymerase Chain Reaction (PCR) tests for COVID-19, and an effective public health approach, is key to managing the risk of new outbreaks in Australia and New Zealand.

29 May, 2020

The Royal College of Pathologists of Australasia (RCPA) supports the use of self-collection for COVID-19 Polymerase Chain Reaction (PCR) tests, when performed under the direction of a medical professional. During a recent trial, self-collected specimens were shown to be an acceptable alternative to specimens collected by healthcare workers and will therefore help to meet demand for COVID-19 testing in the community.


Displaying results 1 - 10 of 58

Page last updated:

Copyright © 2021 RCPA. All rights reserved.

Top